Gene Fama: When’s the Right Time for Active Investing? Never
The Nobel laureate remains a true believer in efficient markets and passive investing and blasts behavioral economists who "dredge for anomalies."
Gene Fama to Keynote 5th Annual Morningstar ETF Conference
Strategic beta, emerging markets, active management and alternatives are among this year's topics, as well as a keynote presentation from economist and Nobel laureate Eugene Fama.
Is the Market Efficient? Cliff Asness Says Yes, and No
At Morningstar, AQR Capital’s leader presents Fama and Shiller’s arguments and says he has “learned to live with my schizophrenia.”
Brightman, Ferri Slug It Out Over Smart Beta
Is smart beta really better beta? Research Affiliates' Chris Brightman says yes, but Rick Ferri was having none of it at a Morningstar conference debate.
John Bogle, Index Icon, Accused of Timing Market
Servo’s Eric Nelson wrote a blistering critique of Vanguard founder Bogle after an interview in which the indexing icon endorsed tactical allocation.
What We Can and Can’t Predict About Stock Returns
Nobel laureates Fama’s and Shiller’s asset-pricing models are nearly opposite, yet they both got one big thing wrong, Research Affiliates CIO Hsu says.
Shiller vs. Fama: Which Nobel Winner Comes Out on Top?
Research Affiliates teases out the Nobel laureates' distinctive value approaches and finds a yawning gap between them.
From Doom to Boom (and Back): Grantham Sees Stocks Soaring up to 30%, for Now
Stock market scold Jeremy Grantham expects the U.S. market to soar 20% to 30% in the next year or two—before the next mega-crash, at least.
Robert Shiller: Budget, Debt Fights a ‘Wash’ for Markets
The Nobel Prize-winning Yale economist said equities haven’t really reacted to the crisis one way or another.
Arnott’s Value Firm Grabs Momentum ‘Hot Potato’ in Paper
The risk of a portfolio blowup is high, says Research Affiliates, but momentum investing could improve returns as a short-term add-on.